SCHEMBL9922067

SCHEMBL9922067

c1cc(-c2ccc(-c3ccc(-c4ccc(-n5c6ccccc6c6ncccc65)cc4)cn3)nc2)cc(-n2c3ccccc3c3cnccc32)c1

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 4/20 0.36
MAOA P21397 4/20 0.34
MAOB P27338 4/20 0.34
ACHE P22303 1/20 0.34
KDM4E B2RXH2 1/20 0.33
ATM Q13315 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
CYP1A2 P05177 1/20 0.33
METAP2 P50579 1/20 0.33
AKT1 P31749 4/20 0.31
AKT2 P31751 4/20 0.31
CDK4 P11802 1/20 0.31
CDK6 Q00534 1/20 0.31
AKT3 Q9Y243 2/20 0.31
MAPT P10636 2/20 0.31
HSD17B1 P14061 1/20 0.31
HSD17B2 P37059 1/20 0.31
CYP2D6 P10635 1/20 0.31
MAPK10 P53779 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12919299 0.97 GRM5 (0.38) GRM5MAOAMAOBACHEKDM4E
SCHEMBL12919286 0.93 KDM4E (0.36) GRM5MAOBKDM4EATML3MBTL1
SCHEMBL9921869 0.93 KDM4E (0.39) GRM5MAOAMAOBACHEKDM4E
SCHEMBL12919271 0.93 MAOA (0.39) MAOAMAOBACHEKDM4EATM
SCHEMBL12919298 0.91 GRM5 (0.38) GRM5KDM4EATML3MBTL1CYP1A2
SCHEMBL12919277 0.90 CDK4 (0.39) GRM5MAOAMAOBACHEKDM4E
SCHEMBL969757 0.89 MAOA (0.41) GRM5MAOAMAOBACHEKDM4E
SCHEMBL12919300 0.89 HSD17B1 (0.38) GRM5MAOBKDM4EATML3MBTL1
SCHEMBL12919328 0.88 AKT1 (0.35) GRM5CYP1A2AKT1AKT2AKT3
SCHEMBL12919319 0.87 MAOA (0.38) GRM5MAOAMAOBACHEKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8377573-B2 Compound having substituted pyridyl group and pyridoindole ring structure linked through phenylene group, and organic electroluminescent device HODOGAYA CHEMICAL CO., LTD. (JP) 2013-02-19 US disclosed
US-8377573-B2 Compound having substituted pyridyl group and pyridoindole ring structure linked through phenylene group, and organic electroluminescent device HODOGAYA CHEMICAL CO., LTD. (JP) 2013-02-19 US disclosed
EP-2463288-A1 Compound having substituted pyridyl group and pyridoindole ring structure linked through phenylene group, and organic electroluminescent device Hodogaya Chemical Co., Ltd. (JP) 2012-06-13 EP disclosed
US-20110006291-A1 COMPOUND HAVING SUBSTITUTED PYRIDYL GROUP AND PYRIDOINDOLE RING STRUCTURE LINKED THROUGH PHENYLENE GROUP, AND ORGANIC ELECTROLUMINESCENT DEVICE HODOGAYA CHEMICAL CO. LTD. (JP) 2011-01-13 US disclosed
US-20110006291-A1 COMPOUND HAVING SUBSTITUTED PYRIDYL GROUP AND PYRIDOINDOLE RING STRUCTURE LINKED THROUGH PHENYLENE GROUP, AND ORGANIC ELECTROLUMINESCENT DEVICE HODOGAYA CHEMICAL CO. LTD. (JP) 2011-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110006291-A1 COMPOUND HAVING SUBSTITUTED PYRIDYL GROUP AND PYRIDOINDOLE RING STRUCTURE LINKED THROUGH PHENYLENE GROUP, AND ORGANIC ELECTROLUMINESCENT DEVICE KCNH3, KCNH2, CHRNA9 GRM5 2016/4885MAOA 599/4885MAOB 360/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.